Edition:
United States

Alexion Pharmaceuticals Inc (ALXN.OQ)

ALXN.OQ on NASDAQ Stock Exchange Global Select Market

121.07USD
18 May 2018
Change (% chg)

-- (--)
Prev Close
$121.07
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
743,262
52-wk High
$149.17
52-wk Low
$96.18

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Mar '18 930.90 1.285
FY 2017 Dec '17 910.10 0.340
Sep '17 859.00 0.347
Jun '17 912.00 0.733
Mar '17 870.00 0.752
FY 2016 Dec '16 830.74 0.405
Sep '16 799.11 0.417
Jun '16 753.12 0.509
Mar '16 701.04 0.406
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Jun-18 14 977.81 1,000.50 957.00 979.95
Quarter Ending Sep-18 14 1,024.03 1,112.50 995.14 1,037.41
Year Ending Dec-18 17 4,000.35 4,253.03 3,946.03 4,044.97
Year Ending Dec-19 19 4,672.74 5,021.72 4,396.00 4,807.46
Earnings (per share)
Quarter Ending Jun-18 17 1.70 1.84 1.59 1.61
Quarter Ending Sep-18 17 1.79 2.00 1.70 1.75
Year Ending Dec-18 18 7.01 7.56 6.80 6.60
Year Ending Dec-19 19 8.54 9.39 8.00 8.53
LT Growth Rate (%) 8 17.36 21.50 15.00 18.65
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) 44.75 28.57 32.53
P/E High - Last 5 Yrs. 285.27 41.44 47.11
P/E Low - Last 5 Yrs. 55.11 23.40 24.61
Beta 1.14 0.80 0.79
Price to Sales (TTM) 7.46 4.06 8.85
Price to Book (MRQ) 2.96 3.49 4.22
Price to Tangible Book (MRQ) 133.98 4.40 5.79
Price to Cash Flow (TTM) 24.38 19.79 21.98
% Owned Institutions 95.60 1.27 2.39

Dividends

  Company industry sector
Dividend Yield -- 1.80 1.67
Dividend Yield - 5 Year Avg -- 0.79 0.80
Dividend 5 Year Growth Rate -- 2.73 4.12
Payout Ratio(TTM) 0.00 16.85 17.66

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago 7.00 3.97 5.06
Sales (TTM) vs TTM 1 Yr. Ago 11.04 10.12 12.43
Sales - 5 Yr. Growth Rate 25.64 7.45 8.11
EPS (MRQ) vs Qtr. 1 Yr. Ago 70.86 37.00 32.52
EPS (TTM) vs TTM 1 Yr. Ago 28.48 -- --
EPS - 5 Yr. Growth Rate 11.07 7.09 8.54
Capital Spending - 5 Yr. Growth Rate 74.88 8.30 8.79

Financial Strength

  Company industry sector
Quick Ratio (MRQ) 2.86 2.52 2.50
Current Ratio (MRQ) 3.35 3.58 3.56
LT Debt to Equity (MRQ) 33.24 10.34 12.76
Total Debt to Equity (MRQ) 35.08 12.69 15.69
Interest Coverage (TTM) 9.30 40.07 34.90

Profitability Ratios

  Company industry sector
Gross Margin (TTM) 86.80 55.56 54.71
Gross Margin - 5 Yr. Avg. 90.11 52.71 52.74
EBITD Margin (TTM) 35.97 -- --
EBITD - 5 Yr. Avg 36.58 18.51 15.91
Operating Margin (TTM) 18.90 13.07 -1.83
Operating Margin - 5 Yr. Avg. 24.78 14.25 11.18
Pre-Tax Margin (TTM) 19.53 13.35 0.25
Pre-Tax Margin - 5 Yr. Avg. 23.19 14.52 11.38
Net Profit Margin (TTM) 16.79 9.76 -3.16
Net Profit Margin - 5 Yr. Avg. 14.91 10.80 7.67
Effective Tax Rate (TTM) 14.01 22.46 31.64
Effective Tax Rate - 5 Yr. Avg. 35.69 23.90 24.59

Efficiency

  Company industry sector
Revenue/Employee (TTM) 1,430,495 836,134,495 726,901,196
Net Income/Employee (TTM) 240,238 97,299,163 84,519,443
Receivable Turnover (TTM) 5.03 5.53 5.67
Inventory Turnover (TTM) 1.12 2.49 3.53
Asset Turnover (TTM) 0.26 0.87 0.85

Management Effectiveness

  Company industry sector
Return on Assets (TTM) 4.45 10.46 9.99
Return on Assets - 5 Yr. Avg. 4.63 11.69 11.11
Return on Investment (TTM) 4.76 13.08 12.63
Return on Investment - 5 Yr. Avg. 5.03 15.12 14.39
Return on Equity (TTM) 6.75 14.80 14.50
Return on Equity - 5 Yr. Avg. 6.92 16.36 15.75
  1 Year 3 Year 5 Year
Sales % 15.15 16.71 25.64
EPS (TTM) % 23.45 -12.67 11.07
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Alexion Pharmaceuticals Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week 12.33 10.56 99 6
13 Week 0.50 1.21 99 12
26 Week 9.20 3.80 99 11
52 Week 3.77 -9.51 99 10
YTD 1.24 -0.23 99 9
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 95.55%
# of Holders: 857
Total Shares Held: 212,594,331
3 Mo. Net Change: -3,477,673
# New Positions: 78
# Closed Positions: 79
# Increased Positions: 353
# Reduced Positions: 382
# Net Buyers: -29
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.